NCT05016193Completed
Independent Use of Brain Measurement-Based Rehabilitation System by Stroke Survivors
Independent Use of Brain Measurement-Based Rehabilitation System by Stroke Survivors: A Randomized Open Label Phase 1 Clinical Trial With Blinded Evaluation
Source: ClinicalTrials.gov · Last updated 13 Aug 2024
Brief summary (registry, in English)
The Axem Home study is a randomized open label trial analyzing the safety and feasibility of coupling the Axem Home prototype device with exercise to improve motor recovery following a stroke.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 8 Feb 2021
- Start date
- 1 Aug 2021
- Primary completion date
- 1 Aug 2024
- Lead sponsor
- University of Calgary
- Diseases
- Stroke
- NCT number
- NCT05016193
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Aug 2021 to the primary completion date, 1 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Score ≥15 on the PHQ-9
- Score \<10 on the MoCA or \<20 on the CASP
- Inclusion in another interventional trial
- Have open wounds on their scalp
Who the study is looking for
- Accepted into the Calgary Stroke Program's Early Supported Discharge program for stroke survivors
- Aged 18 or older
- Visual acuity better than 20/50 in both eyes
- Able to give consent
- Clinician reported upper-extremity movement deficit
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Calgary Stroke Program Early Supported Discharge Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.